PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort to save lives.
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Founded:
2016-04-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Apache Wordpress Plugins
Similar Organizations
Clincierge
Clincierge enables patients to connect more effectively with clinical trials of new medicines.
HealthVerity
HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data.
VitalTrax
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-06 | ArsenalBio | Parker Institute for Cancer Immunotherapy investment in Series B - ArsenalBio | 220 M USD |
2022-06-09 | Senti Biosciences | Parker Institute for Cancer Immunotherapy investment in Post-IPO Equity - Senti Biosciences | 50.6 M USD |
2022-03-22 | Affini-T Therapeutics | Parker Institute for Cancer Immunotherapy investment in Venture Round - Affini-T Therapeutics | 175 M USD |
2019-10-17 | ArsenalBio | Parker Institute for Cancer Immunotherapy investment in Series A - ArsenalBio | 85 M USD |
2018-04-19 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Series A - Tmunity Therapeutics | 35 M USD |
2018-01-23 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Series A - Tmunity Therapeutics | 100 M USD |
2017-09-14 | ImaginAb | Parker Institute for Cancer Immunotherapy investment in Venture Round - ImaginAb | 8 M USD |
2015-12-09 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Seed Round - Tmunity Therapeutics | 10 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-07-23 | Parker Institute Adds John Connolly as New Chief Scientific Officer |
More informations about "Parker Institute for Cancer Immunotherapy"
The Parker Institute for Cancer Immunotherapy
Over 40 laboratories and more than 300 researchers and immunologists from the country’s leading cancer centers are part of the network. Each Parker Institute research center receives …See details»
Leadership & Staff - Parker Institute for Cancer Immunotherapy
Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators. About. ... Parker Foundation. Tom van …See details»
Our Model | Parker Institute for Cancer Immunotherapy
PICI’s model unites the forces and fast-tracks cancer research into real-world results. The Parker Institute brings together the world’s brightest minds to push the boundaries in cancer …See details»
Parker Institute for Cancer Immunotherapy | Memorial …
The Parker Institute for Cancer Immunotherapy is an unprecedented collaboration among 300 of the country’s leading immunologists at six academic cancer centers, all dedicated to a single mission: harnessing the power of the immune …See details»
Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy has established an unprecedented collaboration that brings together more than 300 of the country's leading immunologists at top cancer research institutions nationwide, all …See details»
Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy (PICI) is an unprecedented collaboration among the world’s leading researchers, doctors, and cancer centers, all dedicated to a single mission: accelerate the development of …See details»
Parker Institute for Cancer Immunotherapy | Medical …
Apr 13, 2016 The new Parker Institute for Cancer Immunotherapy at Stanford Medicine was founded with a $250 million grant from the Parker Foundation. Learn more about their work. ... and the University of Texas MD Anderson …See details»
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb …
Mar 28, 2017 CRI is a nonprofit organization dedicated to advancing laboratory and clinical research through its global network of academic, industry, and nonprofit partners with the goal …See details»
Parker Institute for Cancer Immunotherapy - Crunchbase
The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians, and industry partners. The company strives to build a smarter and more coordinated cancer …See details»
Tech leader’s $125m boosts Parker Institute’s …
Jul 19, 2024 The Parker Institute for Cancer Immunotherapy (PICI), a research network launched by Silicon Valley entrepreneur Sean Parker, has announced a new $125 million investment. This is the largest investment for the network …See details»
Parker Institute For Cancer Immunotherapy - ProPublica
Use this database to find organizations and see details like their executive compensation, revenue and expenses, as well as download tax filings going back as far as 2001. ... Parker Institute …See details»
Mission & Vision - Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy breaks down these barriers and focuses fully on this durable and promising treatment. The result is groundbreaking new research and an …See details»
Parker Institute for Cancer Immunotherapy - Charity Navigator
Parker Institute for Cancer Immunotherapy has earned a 4/4 Star rating on Charity Navigator. This Charitable Organization is headquartered in SAN FRANCISCO, CA. ... Simply enter the …See details»
Leucine zipper-based immunomagnetic purification of CAR T cells ...
4 days ago Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA Scott E. James, Santosha A. Vardhana, Christopher A. Klebanoff …See details»
Dipti Patel-Donnelly, MD - Virginia Cancer Specialists
Feb 1, 2024 Dr. Patel-Donnelly is the President of Virginia Cancer Specialists and has played an active role in the local and medical communities. Dr. Patel-Donnelly holds memberships and …See details»
C. Bryce Johnson, MD, PhD - Radiation Oncology
Dr. Johnson has authored dozens of peer-reviewed publications and has won multiple prestigious research grants, including the F30 National Research Service Award and a Parker Institute for …See details»
New immunotherapy platform could increase potential to target …
Dec 18, 2024 Immunotherapy presents a promising strategy for treating cancer, autoimmune diseases, and viral infections, but its effectiveness depends on its ability to target diseases cells.See details»
Sean Parker - Parker Institute for Cancer Immunotherapy
In April 2016, the Parker Foundation announced a $250 million grant to form the Parker Institute for Cancer Immunotherapy, building on Mr. Parker’s leadership in funding and promoting …See details»
Inhibiting intracellular CD28 in cancer cells enhances antitumor ...
Dec 3, 2024 Deciphering mechanisms for cancer immune escape may provide targets for improving immunotherapy efficacy. By in vivo genome-wide CRISPR loss-of-function …See details»
David Z. Chang, M.D., Ph.D., FACP - virginiacancer.com
Cleveland Clinic Foundation | Internal Medicine. Residency. Cleveland Clinic Foundation | Internal Medicine. ... /National Cancer Institute (NCI). ... Journal of Immunotherapy, Clinical Cancer …See details»